Ovid Therapeutics (OVID) Amortizatization of Intangibles (2022 - 2026)
Ovid Therapeutics (OVID) reported Amortizatization of Intangibles of $312000.0 for Q1 2026, up 8.33% on a YoY basis from $288000.0 in Q1 2025, and up 2.3% quarter-over-quarter from $305000.0 in Q4 2025.
Ovid Therapeutics (OVID) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Ovid Therapeutics has reported Amortizatization of Intangibles for 5 years, with the latest figure at $312000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 8.33% year-over-year to $312000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 8.22% YoY), and the FY2025 full-year result was $1.2 million, up 8.2% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $312000.0, up from $305000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $354185.0 in Q2 2022, with the low at $253000.0 in Q1 2023.
- Historically, Amortizatization of Intangibles has averaged $280818.8 across 5 years, with a median of $274500.0 in 2024.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles decreased 27.16% — and 2026, when it grew 8.33%.
- Ovid Therapeutics' Amortizatization of Intangibles stood at $254970.0 in 2022, then climbed by 2.36% to $261000.0 in 2023, then grew by 8.05% to $282000.0 in 2024, then grew by 8.16% to $305000.0 in 2025, then advanced by 2.3% to $312000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $312000.0 (Q1 2026), $305000.0 (Q4 2025), and $300000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - | 312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | 305,000.00 |
| Dec 31, 2025 | 305,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 294,000.00 |
| Jun 30, 2025 | 294,000.00 |
| Mar 31, 2025 | 288,000.00 |
| Mar 31, 2025 | 288,000.00 |
| Dec 31, 2024 | 282,000.00 |
| Dec 31, 2024 | 282,000.00 |
| Sep 30, 2024 | 277,000.00 |
| Sep 30, 2024 | 277,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Dec 31, 2023 | 261,000.00 |
| Dec 31, 2023 | 261,000.00 |